Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy And Safety Study Of BTRX-246040 Administered Once Daily In Patients With Major Depressive Disorder With Or Without Anhedonia
NCT03193398 is registered in ClinicalTrials.gov with BlackThorn Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy And Safety Study Of BTRX-246040 Administered Once Daily In Patients With Major Depressive Disorder With Or Without Anhedonia
- Lead sponsor
- BlackThorn Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 12, 2017
- Completion date
- December 12, 2018
- Enrollment
- 104 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.